BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 3 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Recs

0
Player Avatar GenFrogKing7 (90.84) Submitted: 10/1/2012 4:39:37 PM : Underperform Start Price: $6.62 BDSI Score: +21.97

It's getting real close to its all-time high. One look at the charts strongly suggests a down turn. It's only a matter of time!

Featured Broker Partners


Advertisement